SARS-CoV-2: the Emergence of a Viral Pathogen Causing Havoc on Human Existence

Overview

Journal J Genet

Specialty Genetics

Date 2020 Jun 3

PMID 32482926

Citations 9

Authors

Ashish Prasad

Manoj Prasad

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 was first reported from Wuhan district of China and has spread to 210 countries across the world claiming over 97,602 human lives as on 10 April 2020 by 21:06 pm. Currently, there is no specific treatment for this virus and the treatment is mainly relied on controlling symptoms. Here we discuss our current understanding of SARS-CoV-2 with respect to its receptor recognition and how this knowledge could be useful in treatment using clinically known inhibitory drugs. We have also discussed the diagnosis, treatment and preventive measures that are currently being employed for controlling further spread of the virus.

Citing Articles

Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function.

Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A Pathol Res Pract. 2022; 231:153782.

PMID: 35121363 PMC: 8800420. DOI: 10.1016/j.prp.2022.153782.

Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2.

Rashid H, Ahmad N, Abdalla M, Khan K, Martines M, Shabana S J Mol Struct. 2021; 1247:131296.

PMID: 34404957 PMC: 8362340. DOI: 10.1016/j.molstruc.2021.131296.

Research and leaders: a twisted tale!.

Prasad A, Prasad M Trends Genet. 2021; 37(10):863-864.

PMID: 34218957 PMC: 8436586. DOI: 10.1016/j.tig.2021.06.013.

Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.

Singh R, Singh P, Kumar R, Kabir M, Kamal M, Rauf A Front Pharmacol. 2021; 12:652335.

PMID: 34054532 PMC: 8149611. DOI: 10.3389/fphar.2021.652335.

Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study.

Josa-Laorden C, Crestelo-Vieitez A, Garcia Andreu M, Rubio-Rivas M, Sanchez M, Toledo Samaniego N J Clin Med. 2021; 10(5).

PMID: 33668766 PMC: 7956359. DOI: 10.3390/jcm10050899.

References

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Mubarak A, Alturaiki W, Hemida M . Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development. J Immunol Res. 2019; 2019:6491738. PMC: 6476043. DOI: 10.1155/2019/6491738. View

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

Andersen K, Rambaut A, Lipkin W, Holmes E, Garry R . The proximal origin of SARS-CoV-2. Nat Med. 2020; 26(4):450-452. PMC: 7095063. DOI: 10.1038/s41591-020-0820-9. View

Keidar S, Kaplan M, Gamliel-Lazarovich A . ACE2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc Res. 2006; 73(3):463-9. DOI: 10.1016/j.cardiores.2006.09.006. View

Bar-On Y, Flamholz A, Phillips R, Milo R . SARS-CoV-2 (COVID-19) by the numbers. Elife. 2020; 9. PMC: 7224694. DOI: 10.7554/eLife.57309. View

de Wit E, van Doremalen N, Falzarano D, Munster V . SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14(8):523-34. PMC: 7097822. DOI: 10.1038/nrmicro.2016.81. View

van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B . Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020; 382(16):1564-1567. PMC: 7121658. DOI: 10.1056/NEJMc2004973. View

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

10.

Gbinigie K, Frie K . Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review. BJGP Open. 2020; 4(2). PMC: 7330219. DOI: 10.3399/bjgpopen20X101069. View

11.

Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

12.

Rengasamy S, Shaffer R, Williams B, Smit S . A comparison of facemask and respirator filtration test methods. J Occup Environ Hyg. 2016; 14(2):92-103. PMC: 7157953. DOI: 10.1080/15459624.2016.1225157. View

13.

Forster P, Forster L, Renfrew C, Forster M . Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020; 117(17):9241-9243. PMC: 7196762. DOI: 10.1073/pnas.2004999117. View

14.

Raj V, Mou H, Smits S, Dekkers D, Muller M, Dijkman R . Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495(7440):251-4. PMC: 7095326. DOI: 10.1038/nature12005. View

15.

Holshue M, DeBolt C, Lindquist S, Lofy K, Wiesman J, Bruce H . First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929-936. PMC: 7092802. DOI: 10.1056/NEJMoa2001191. View

16.

Poon L, Peiris M . Emergence of a novel human coronavirus threatening human health. Nat Med. 2020; 26(3):317-319. PMC: 7095779. DOI: 10.1038/s41591-020-0796-5. View

17.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

18.

Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan Y . A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020; 7(1):4. PMC: 7003341. DOI: 10.1186/s40779-020-0233-6. View

19.

Duan K, Liu B, Li C, Zhang H, Yu T, Qu J . Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020; 117(17):9490-9496. PMC: 7196837. DOI: 10.1073/pnas.2004168117. View

20.

Gurwitz D . Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020; 81(5):537-540. PMC: 7228359. DOI: 10.1002/ddr.21656. View